{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:41:06Z","timestamp":1782481266192,"version":"3.54.5"},"reference-count":165,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jaip.2023.08.038","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T11:56:03Z","timestamp":1693569363000},"page":"3289-3303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["COVID-19 and Its Impact on Common Diseases in the Allergy Clinics"],"prefix":"10.1016","volume":"11","author":[{"given":"Emek","family":"Kocat\u00fcrk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa M.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jad","family":"Mitri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Oppenheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Zein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2023.08.038_bib1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/14737167.2020.1819793","article-title":"Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy","volume":"20","author":"Dierick","year":"2020","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.jaip.2023.08.038_bib2","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jaci.2017.07.025","article-title":"Viral infections in allergy and immunology: how allergic inflammation influences viral infections and illness","volume":"140","author":"Edwards","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.08.038_bib3","series-title":"StatPearls. Treasure Island","article-title":"Features, evaluation, and treatment of coronavirus (COVID-19)","author":"Cascella","year":"2023"},{"key":"10.1016\/j.jaip.2023.08.038_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12097","article-title":"Allergic patients during the COVID-19 pandemic\u2014clinical practical considerations: an European Academy of Allergy and Clinical Immunology survey","volume":"12","author":"Alvaro-Lozano","year":"2022","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2023.08.038_bib6","series-title":"The Role of Telehealth in an Evolving Health Care Environment: Workshop Summary","article-title":"The evolution of telehealth: where have we been and where are we going?","year":"2012"},{"key":"10.1016\/j.jaip.2023.08.038_bib7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.anai.2020.06.027","article-title":"Patient satisfaction with telemedicine encounters in an allergy and immunology practice during the coronavirus disease 2019 pandemic","volume":"125","author":"Mustafa","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.08.038_bib9","article-title":"Clinic vs home spirometry for monitoring lung function in patients with asthma","author":"Oppenheimer","year":"2023","journal-title":"Chest. Published online June 27"},{"key":"10.1016\/j.jaip.2023.08.038_bib10","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.jaip.2020.05.007","article-title":"Health and economic outcomes of home maintenance allergen immunotherapy in select patients with high health literacy during the COVID-19 pandemic: a cost-effectiveness analysis during exceptional times","volume":"8","author":"Shaker","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib11","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.jaip.2020.03.012","article-title":"COVID-19: pandemic contingency planning for the allergy and immunology clinic","volume":"8","author":"Shaker","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaip.2019.09.037","article-title":"Estimation of health and economic benefits of clinic versus home administration of omalizumab and mepolizumab","volume":"8","author":"Shaker","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib13","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jaip.2022.05.022","article-title":"Factors related to biologic adherence and outcomes among moderate-to-severe asthma patients","volume":"10","author":"Osazuwa-Peters","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World Allergy Organization anaphylaxis guidance 2020","volume":"13","author":"Cardona","year":"2020","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2023.08.038_bib15","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jaip.2020.04.022","article-title":"Acute at home management of anaphylaxis during the Covid-19 pandemic","volume":"8","author":"Casale","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib16","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.anai.2023.01.015","article-title":"Retire the advice to send patients to the emergency department after epinephrine use for observation","volume":"130","author":"Greenhawt","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.08.038_bib17","doi-asserted-by":"crossref","first-page":"e689","DOI":"10.1002\/ams2.689","article-title":"Incidence and timing of biphasic anaphylactic reactions: a retrospective cohort study","volume":"8","author":"Ichikawa","year":"2021","journal-title":"Acute Med Surg"},{"key":"10.1016\/j.jaip.2023.08.038_bib18","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal anaphylaxis: mortality rate and risk factors","volume":"5","author":"Turner","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib19","article-title":"Evaluation of prehospital management in a Canadian emergency department anaphylaxis cohort","volume":"7","author":"Gabrielli","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.anai.2018.06.035","article-title":"An economic evaluation of immediate vs non-immediate activation of emergency medical services after epinephrine use for peanut-induced anaphylaxis","volume":"122","author":"Shaker","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.08.038_bib21","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.anai.2021.07.006","article-title":"Anaphylaxis-related knowledge and concerns in Canadian families during the coronavirus disease 2019 pandemic","volume":"127","author":"Gabrielli","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.08.038_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.anai.2020.09.012","article-title":"Factors contributing to underuse of epinephrine autoinjectors in pediatric patients with food allergy","volume":"126","author":"Glassberg","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.08.038_bib23","doi-asserted-by":"crossref","first-page":"725165","DOI":"10.3389\/falgy.2021.725165","article-title":"Home-based peanut oral immunotherapy for low-risk peanut-allergic preschoolers during the COVID-19 pandemic and beyond","volume":"2","author":"Chua","year":"2021","journal-title":"Front Allergy"},{"key":"10.1016\/j.jaip.2023.08.038_bib24","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1016\/j.jaip.2021.05.012","article-title":"Web-based Infant Food Introduction (WIFI): feasibility and satisfaction of virtual allergist-supervised food introduction","volume":"9","author":"Latrous","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib25","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1016\/j.jaip.2020.07.020","article-title":"Novel approaches to food allergy management during COVID-19 inspire long-term change","volume":"8","author":"Mack","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib26","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/all.12901","article-title":"Definition, aims, and implementation of GA(2) LEN Urticaria Centers of Reference and Excellence","volume":"71","author":"Maurer","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.08.038_bib27","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/all.14687","article-title":"The global impact of the COVID-19 pandemic on the management and course of chronic urticaria","volume":"76","author":"Kocat\u00fcrk","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.08.038_bib28","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/all.14767","article-title":"Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: data from the DA-COVID-19 registry","volume":"76","author":"Chiricozzi","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.08.038_bib29","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-2600(21)00013-8","article-title":"Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterization Protocol UK","volume":"9","author":"Bloom","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.08.038_bib30","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S2213-2600(20)30447-1","article-title":"Inhaled corticosteroids and COVID-19-related mortality: confounding or clarifying?","volume":"8","author":"Singh","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.08.038_bib31","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1016\/j.jaip.2021.07.030","article-title":"Asthma disease status, COPD, and COVID-19 severity in a large multiethnic population","volume":"9","author":"Huang","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib32","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S2213-2600(20)30415-X","article-title":"Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform","volume":"8","author":"Schultze","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.08.038_bib33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jaip.2021.10.049","article-title":"Impact of allergic rhinitis and asthma on COVID-19 infection, hospitalization, and mortality","volume":"10","author":"Ren","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S2213-2600(21)00543-9","article-title":"Public Health Scotland and the EAVE II Collaborators. Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort study","volume":"10","author":"Shi","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.08.038_bib35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S2213-2600(21)00491-4","article-title":"Public Health Scotland and the EAVE II Collaborators. Risk of COVID-19 hospital admission among children aged 5-17 years with asthma in Scotland: a national incident cohort study","volume":"10","author":"Shi","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.08.038_bib36","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1080\/02770903.2021.2018703","article-title":"Clinical outcomes among hospitalized US adults with asthma or chronic obstructive pulmonary disease, with or without COVID-19","volume":"59","author":"Cornwell","year":"2022","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.jaip.2023.08.038_bib37","doi-asserted-by":"crossref","DOI":"10.1177\/17534666221091183","article-title":"Uncontrolled asthma predicts severe COVID-19: a report from the Swedish National Airway Register","volume":"16","author":"Karlsson Sundbaum","year":"2022","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.jaip.2023.08.038_bib38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/thoraxjnl-2021-218629","article-title":"Relationship between asthma and severe COVID-19: a national cohort study","volume":"78","author":"Dolby","year":"2023","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2023.08.038_bib39","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1365-2222.2011.03929.x","article-title":"Severe asthma: from characteristics to phenotypes to endotypes","volume":"42","author":"Wenzel","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.08.038_bib40","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1164\/rccm.201607-1407OC","article-title":"Gene expression correlated with severe asthma characteristics reveals heterogeneous mechanisms of severe disease","volume":"195","author":"Modena","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.08.038_bib41","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1164\/rccm.201612-2572ED","article-title":"Using network analysis to understand severe asthma phenotypes","volume":"195","author":"Jones","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.08.038_bib42","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s12890-022-02230-5","article-title":"Patients with allergic asthma have lower risk of severe COVID-19 outcomes than patients with nonallergic asthma","volume":"22","author":"Murphy","year":"2022","journal-title":"BMC Pulmon Med"},{"key":"10.1016\/j.jaip.2023.08.038_bib43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaci.2020.04.009","article-title":"Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2","volume":"146","author":"Jackson","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.08.038_bib44","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1016\/j.jacc.2020.04.028","article-title":"Clinical implications of SARS-CoV-2 interaction with renin angiotensin system: JACC review topic of the week","volume":"75","author":"Brojakowska","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaip.2023.08.038_bib45","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s12026-008-8058-5","article-title":"Eosinophils and their interactions with respiratory virus pathogens","volume":"43","author":"Rosenberg","year":"2009","journal-title":"Immunol Res"},{"key":"10.1016\/j.jaip.2023.08.038_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1165\/rcmb.2006-0457OC","article-title":"Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils","volume":"37","author":"Wong","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaip.2023.08.038_bib47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/vim.2018.0150","article-title":"Eosinophils and respiratory viruses","volume":"32","author":"Flores-Torres","year":"2019","journal-title":"Viral Immunol"},{"key":"10.1016\/j.jaip.2023.08.038_bib48","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jaip.2020.12.045","article-title":"Eosinophilia in asthma patients is protective against severe COVID-19 illness","volume":"9","author":"Ferastraoaru","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2020.04.021","article-title":"Eosinophil responses during COVID-19 infections and coronavirus vaccination","volume":"146","author":"Lindsley","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.08.038_bib50","article-title":"Clinical outcome of eosinophilia in patients with COVID-19: a controlled study","volume":"91","author":"Nair","year":"2020","journal-title":"Acta Biomed"},{"key":"10.1016\/j.jaip.2023.08.038_bib51","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jaip.2021.12.034","article-title":"Eosinophilia is associated with improved COVID-19 outcomes in inhaled corticosteroid-treated patients","volume":"10","author":"Zein","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib52","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jaci.2020.09.034","article-title":"Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon","volume":"147","author":"Finney","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.08.038_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01648-20","article-title":"The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells","volume":"95","author":"Matsuyama","year":"2020","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jaip.2023.08.038_bib54","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.08.038_bib55","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1016\/j.jaip.2021.08.007","article-title":"Intranasal corticosteroids are associated with better outcomes in coronavirus disease 2019","volume":"9","author":"Strauss","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib56","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S2213-2600(21)00160-0","article-title":"Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial","volume":"9","author":"Ramakrishnan","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.08.038_bib57","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(21)01744-X","article-title":"Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial","volume":"398","author":"Yu","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2023.08.038_bib58","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.08.038_bib59","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jaip.2021.10.041","article-title":"The relationship of asthma severity to COVID-19 outcomes","volume":"10","author":"Zein","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib60","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2023.08.038_bib61","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1016\/j.jaip.2021.08.025","article-title":"Corticosteroid protection against COVID-19: begin with the nose","volume":"9","author":"Lipworth","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib62","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.jaip.2020.05.012","article-title":"A\u00a0phased approach to resuming suspended allergy\/immunology clinical services","volume":"8","author":"Searing","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib63","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1016\/j.jaip.2020.08.044","article-title":"Increasing awareness of the low risk of severe reaction at infant peanut introduction: implications during COVID-19 and beyond","volume":"8","author":"Abrams","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib64","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.jaip.2020.03.047","article-title":"Prehospital treatment and emergency department outcomes in young children with food allergy","volume":"8","author":"Ko","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib65","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.anai.2018.05.025","article-title":"Food-induced anaphylaxis in infants and children","volume":"121","author":"Samady","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.08.038_bib66","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJMoa1514210","article-title":"Randomized trial of introduction of allergenic foods in breast-fed infants","volume":"374","author":"Perkin","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.08.038_bib67","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa1414850","article-title":"Randomized trial of peanut consumption in infants at risk for peanut allergy","volume":"372","author":"Du Toit","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.08.038_bib68","author":"Abrams"},{"key":"10.1016\/j.jaip.2023.08.038_bib69","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jaip.2020.11.002","volume":"9","author":"Fleischer","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib70","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1399-3038.2010.01093.x","article-title":"Childhood acute urticaria in northern and southern Europe shows a similar epidemiological pattern and significant meteorological influences","volume":"22","author":"Konstantinou","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.08.038_bib71","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fimmu.2015.00238","article-title":"Mast cells and influenza A virus: association with allergic responses and beyond","volume":"6","author":"Graham","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2023.08.038_bib72","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12967-022-03382-y","article-title":"Early and strong antibody responses to SARS-CoV-2 predict disease severity in COVID-19 patients","volume":"20","author":"Pl\u016bme","year":"2022","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.jaip.2023.08.038_bib73","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jdin.2020.12.003","article-title":"Skin manifestations of COVID-19: a worldwide review","volume":"2","author":"Tan","year":"2021","journal-title":"JAAD Int"},{"key":"10.1016\/j.jaip.2023.08.038_bib74","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bjd.19163","article-title":"Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases","volume":"183","author":"Galv\u00e1n Casas","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2023.08.038_bib75","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1111\/jdv.16472","article-title":"Urticarial eruption in COVID-19 infection","volume":"34","author":"Henry","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2023.08.038_bib76","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s13555-021-00526-8","article-title":"Time of onset of selected skin lesions associated with COVID-19: a systematic review","volume":"11","author":"Gisondi","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jaip.2023.08.038_bib77","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jaad.2020.06.1016","article-title":"The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries","volume":"83","author":"Freeman","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2023.08.038_bib78","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2147\/CCID.S325552","article-title":"Synthesis of the data on COVID-19 skin manifestations: underlying mechanisms and potential outcomes","volume":"14","author":"Farinazzo","year":"2021","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.jaip.2023.08.038_bib79","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1473-3099(20)30986-5","article-title":"Long COVID in the skin: a registry analysis of COVID-19 dermatological duration","volume":"21","author":"McMahon","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jaip.2023.08.038_bib80","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14290","article-title":"Urticaria and COVID-19: a review","volume":"33","author":"Algaadi","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaip.2023.08.038_bib81","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1159\/000530610","article-title":"Features of chronic spontaneous urticaria induced by COVID-19","volume":"184","author":"\u00d6zta\u015f Kara","year":"2023","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.08.038_bib82","first-page":"1144","article-title":"COVID-19 disease leading to chronic spontaneous urticaria exacerbation: a Romanian retrospective study","volume":"9","author":"Muntean","year":"2021","journal-title":"Healthc (Basel, Switzerland)"},{"key":"10.1016\/j.jaip.2023.08.038_bib83","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/jdv.17635","article-title":"COVID-19 and skin diseases: results from a survey of 843 patients with atopic dermatitis, psoriasis, vitiligo and chronic urticaria","volume":"36","author":"Criado","year":"2022","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2023.08.038_bib84","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1111\/jdv.18294","article-title":"Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: a systematic review and meta-analysis","volume":"36","author":"Washrawirul","year":"2022","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2023.08.038_bib85","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jamadermatol.2021.2114","article-title":"Incidence of cutaneous reactions after messenger RNA COVID-19 vaccines","volume":"157","author":"Robinson","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2023.08.038_bib86","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1111\/all.15241","article-title":"Allergies and COVID-19 vaccines: an ENDA\/EAACI Position paper","volume":"77","author":"Barbaud","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.08.038_bib87","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jdcr.2022.05.011","article-title":"Chronic spontaneous urticaria following COVID-19 vaccination","volume":"25","author":"de Montjoye","year":"2022","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaip.2023.08.038_bib88","doi-asserted-by":"crossref","DOI":"10.1177\/21526567211068458","article-title":"Chronic spontaneous urticaria triggered by the AstraZeneca\/Oxford COVID-19 vaccine with achieved remission: a case report","volume":"13","author":"Brooks","year":"2022","journal-title":"Allergy Rhinol (Providence)"},{"key":"10.1016\/j.jaip.2023.08.038_bib89","article-title":"Chronic spontaneous urticaria after COVID-19 vaccine","volume":"13","author":"Thomas","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jaip.2023.08.038_bib90","article-title":"COVID-19 vaccine booster-induced dermatographism","volume":"14","author":"Amjad","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jaip.2023.08.038_bib91","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jdcr.2022.05.012","article-title":"Chronic spontaneous urticaria after COVID-19 primary vaccine series and boosters","volume":"25","author":"Strahan","year":"2022","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaip.2023.08.038_bib92","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jaip.2022.12.010","article-title":"Urticaria after COVID-19 vaccination and vaccine hesitancy","volume":"11","author":"Judd","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib93","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2500\/aap.2022.43.210111","article-title":"Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2","volume":"43","author":"Magen","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2023.08.038_bib94","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/cea.14214","article-title":"Clinical and immunological data from chronic urticaria onset after mRNA SARS-CoV-2 vaccines","volume":"52","author":"Pescosolido","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.08.038_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103054","article-title":"Characteristics of immune response profile in patients with immediate allergic and autoimmune urticarial reactions induced by SARS-CoV-2 vaccines","volume":"138","author":"Wang","year":"2023","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaip.2023.08.038_bib96","first-page":"3475","article-title":"Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: results of the UCARE COVAC-CU study","volume":"11","author":"Kocaturk","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.08.038_bib97","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1111\/jdv.16411","article-title":"European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)\u2014infection and atopic dermatitis","volume":"34","author":"Wollenberg","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2023.08.038_bib98","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1172\/JCI141772","article-title":"Baricitinib restrains the immune dysregulation in patients with severe COVID-19","volume":"130","author":"Bronte","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2023.08.038_bib99","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaip.2021.10.050","article-title":"COVID-19 symptoms are attenuated in moderate-to-severe atopic dermatitis patients treated with dupilumab","volume":"10","author":"Ungar","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdin.2021.12.007","article-title":"Association between atopic dermatitis and COVID-19 infection: a case-control study in the All of Us research program","volume":"6","author":"Fan","year":"2022","journal-title":"JAAD Int"},{"key":"10.1016\/j.jaip.2023.08.038_bib101","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jaad.2021.09.061","article-title":"The risk of COVID-19 infection in patients with atopic dermatitis: a retrospective cohort study","volume":"86","author":"Wu","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2023.08.038_bib102","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ad.2021.08.013","article-title":"Impact of COVID-19 pandemic on patients with atopic dermatitis","volume":"113","author":"Pourani","year":"2022","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaip.2023.08.038_bib103","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/jdv.18613","article-title":"The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: results from the global SECURE-AD registry","volume":"37","author":"Musters","year":"2023","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2023.08.038_bib104","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15476","article-title":"Dupilumab therapy in atopic dermatitis is safe during COVID-19 infection era: a systematic review and meta-analysis of 1611 patients","volume":"35","author":"El-Qushayri","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaip.2023.08.038_bib105","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaci.2023.05.019","article-title":"Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: a GRADE assessment, and international consensus approach","volume":"152","author":"Greenhawt","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.08.038_bib106","doi-asserted-by":"crossref","first-page":"e409","DOI":"10.1111\/jdv.17964","article-title":"Atopic dermatitis exacerbation after Covid-19 vaccination in dupilumab-treated patients","volume":"36","author":"Potestio","year":"2022","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2023.08.038_bib107","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5021\/ad.22.118","article-title":"Effect of COVID-19 (SARS-CoV-2) vaccination on patients with atopic dermatitis treated with dupilumab: a multicenter, observational study","volume":"35","author":"Han","year":"2023","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaip.2023.08.038_bib108","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jamadermatol.2022.3488","article-title":"Outcomes of COVID-19 and vaccination in patients with moderate to severe atopic dermatitis treated with tralokinumab","volume":"158","author":"Blauvelt","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2023.08.038_bib109","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/cod.13727","article-title":"Increased occurrence of hand eczema in young children following the Danish hand hygiene recommendations during the COVID-19 pandemic","volume":"84","author":"Simonsen","year":"2021","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2023.08.038_bib110","doi-asserted-by":"crossref","first-page":"e1109","DOI":"10.1002\/hsr2.1109","article-title":"Covid-19 histamine theory: why antihistamines should be incorporated as the basic component in Covid-19 management?","volume":"6","author":"Mashauri","year":"2023","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.jaip.2023.08.038_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2020.101942","article-title":"Dual-histamine receptor blockade with cetirizine-famotidine reduces pulmonary\u00a0symptoms in COVID-19 patients","volume":"63","author":"Hogan","year":"2020","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.jaip.2023.08.038_bib112","first-page":"335","article-title":"Antihistamines for postacute sequelae of SARS-CoV-2 infection","volume":"18","author":"Pinto","year":"2022","journal-title":"J\u00a0Nurse Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib113","first-page":"61","article-title":"Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines","volume":"70","author":"Glynne","year":"2022","journal-title":"J\u00a0Invest Med"},{"key":"10.1016\/j.jaip.2023.08.038_bib114","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5414\/ALX02241E","volume":"5","author":"Pfaar","year":"2021","journal-title":"Allergol Select"},{"key":"10.1016\/j.jaip.2023.08.038_bib115","doi-asserted-by":"crossref","DOI":"10.1111\/pai.13851","article-title":"Allergic diseases and immunodeficiencies in children, lessons learnt from COVID-19 pandemic by 2022: a statement from the EAACI-section on pediatrics","volume":"33","author":"Munblit","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.08.038_bib116","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13052-020-00843-2","article-title":"Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic","volume":"46","author":"Cardinale","year":"2020","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.jaip.2023.08.038_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2023.100741","article-title":"Omalizumab may protect allergic patients against COVID-19: a systematic review","volume":"16","author":"Ghiglioni","year":"2023","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2023.08.038_bib120","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jaci.2015.09.008","article-title":"Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations","volume":"136","author":"Teach","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.08.038_bib121","article-title":"The effect of COVID-19 on patients recieving omalizumab treatment","volume":"63","author":"Sayaca","year":"2023","journal-title":"Rev Fr Allergol (2009)"},{"key":"10.1016\/j.jaip.2023.08.038_bib122","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jaci.2021.06.006","article-title":"COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: nationwide real-world evidence","volume":"148","author":"Adir","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.08.038_bib123","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/12034754211049707","article-title":"Incidence of COVID-19 in patients with chronic idiopathic urticaria and asthma on omalizumab: a multicentre retrospective cohort study","volume":"26","author":"Abduelmula","year":"2022","journal-title":"J\u00a0Cutan Med Surg"},{"key":"10.1016\/j.jaip.2023.08.038_bib124","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/all.14558","article-title":"Severe asthma in adults does not significantly affect the outcome of COVID-19 disease: results from the Italian Severe Asthma Registry","volume":"76","author":"Antonicelli","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.08.038_bib125","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/all.14516","article-title":"COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: results from a multicenter Italian survey","volume":"76","author":"Matucci","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.08.038_bib126","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15111","article-title":"Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID-19","volume":"34","author":"Passante","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaip.2023.08.038_bib127","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1111\/all.14407","article-title":"Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: an EAACI statement","volume":"75","author":"Vultaggio","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.08.038_bib128","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5414\/ALX02166E","volume":"4","author":"Klimek","year":"2020","journal-title":"Allergol Select"},{"key":"10.1016\/j.jaip.2023.08.038_bib131","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1111\/ajt.16250","article-title":"Cyclosporine and COVID-19: risk or favorable?","volume":"20","author":"Poulsen","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jaip.2023.08.038_bib132","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1111\/ajt.15970","article-title":"Preliminary data on outcomes of SARS-CoV-2 infection in a Spanish single centre cohort of kidney recipients","volume":"20","author":"Montagud-Marrahi","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jaip.2023.08.038_bib133","article-title":"Covid-19 infection in psoriasis patients treated with cyclosporin","volume":"33","author":"Di Lernia","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaip.2023.08.038_bib134","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/annrheumdis-2021-221575","article-title":"Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations","volume":"81","author":"Kroon","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2023.08.038_bib135","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1002\/art.41596","article-title":"American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3","volume":"73","author":"Mikuls","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaip.2023.08.038_bib136","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/j.jaad.2020.03.046","article-title":"COVID-19 and immunomodulator\/immunosuppressant use in dermatology","volume":"82","author":"Price","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2023.08.038_bib137","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13298","article-title":"COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action","volume":"33","author":"Conforti","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaip.2023.08.038_bib138","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jaad.2020.12.058","article-title":"National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: version 2\u2014advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments","volume":"84","author":"Gelfand","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2023.08.038_bib143","doi-asserted-by":"crossref","DOI":"10.1177\/2042098620985687","article-title":"Systematic review of immunosuppressant guidelines in the COVID-19 pandemic","volume":"12","author":"Barlow-Pay","year":"2021","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.jaip.2023.08.038_bib144","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/jdv.17075","article-title":"Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond","volume":"35","author":"Beecker","year":"2021","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2023.08.038_bib148","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc8511","article-title":"Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications","volume":"369","author":"Mathew","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jaip.2023.08.038_bib149","article-title":"IL-13 is a driver of COVID-19 severity","volume":"6","author":"Donlan","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaip.2023.08.038_bib150","doi-asserted-by":"crossref","first-page":"ofac343","DOI":"10.1093\/ofid\/ofac343","article-title":"Safety and efficacy of dupilumab for the treatment of hospitalized patients with moderate to severe coronavirus disease 2019: a phase 2a trial","volume":"9","author":"Sasson","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jaip.2023.08.038_bib151","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/cid\/ciac745","article-title":"Dupilumab use is associated with protection from coronavirus disease 2019 mortality: a retrospective analysis","volume":"76","author":"Donlan","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2023.08.038_bib152","first-page":"5865","article-title":"Higher rates of COVID-19 but less severe infections reported for patients on dupilumab: a Big Data analysis of the World Health Organization VigiBase","volume":"25","author":"Mahroum","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jaip.2023.08.038_bib156","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1473-3099(20)30132-8","article-title":"COVID-19: combining antiviral and anti-inflammatory treatments","volume":"20","author":"Stebbing","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jaip.2023.08.038_bib157","first-page":"CD015209","article-title":"Janus kinase inhibitors for the treatment of COVID-19","volume":"6","author":"Kramer","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2023.08.038_bib158","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/annrheumdis-2021-220418","article-title":"COVID-19 Global Rheumatology Alliance. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance physician registry","volume":"80","author":"Sparks","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2023.08.038_bib159","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/annrheumdis-2021-219845","article-title":"Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study","volume":"80","author":"Bower","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2023.08.038_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100126","article-title":"COVID-19, asthma, and biological therapies: what we need to know","volume":"13","author":"Morais-Almeida","year":"2020","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2023.08.038_bib162","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/all.14532","article-title":"COVID-19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact of comorbidities and treatments","volume":"76","author":"Heffler","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.08.038_bib163","doi-asserted-by":"crossref","first-page":"AB58","DOI":"10.1016\/j.jaci.2021.12.221","article-title":"COVID-19 infection outcomes in inner city asthmatics treated with biologics","volume":"149","author":"Hudes","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.08.038_bib164","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1111\/all.14353","article-title":"COVID-19, chronic inflammatory respiratory diseases and eosinophils\u2014observations from reported clinical case series","volume":"75","author":"Jesenak","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.08.038_bib117","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/cia2.12248","article-title":"Prior antihistamine agent successfully impaired cutaneous adverse reactions to COVID-19 vaccine","volume":"5","author":"Nanamori","year":"2022","journal-title":"J\u00a0Cutan Immunol Allergy"},{"key":"10.1016\/j.jaip.2023.08.038_bib118","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.jaip.2023.04.050","article-title":"Exacerbation of chronic spontaneous urticaria following coronavirus disease 2019 (COVID-19) vaccination in omalizumab-treated patients","volume":"11","author":"Lee","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.08.038_bib129","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.892277","article-title":"Effectiveness and durability of mRNA vaccine-induced SARS-CoV-2-specific humoral and cellular immunity in severe asthma patients on biological therapy","volume":"13","author":"Podrazil","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2023.08.038_bib130","first-page":"1822","article-title":"Effects of vaccination against COVID-19 in chronic spontaneous and inducible urticaria (CSU\/CIU) patients: a monocentric study","volume":"11","author":"Grieco","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jaip.2023.08.038_bib139","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.737300","article-title":"Immunological response against SARS-COV-2 after BNT162b2 vaccine administration is impaired in allogeneic but not in autologous stem cell transplant recipients","volume":"11","author":"Chiarucci","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jaip.2023.08.038_bib140","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1111\/jdv.17167","article-title":"European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics","volume":"35","author":"Thyssen","year":"2021","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2023.08.038_bib141","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/art.42372","article-title":"American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5","volume":"75","author":"Curtis","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaip.2023.08.038_bib145","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41584-023-00992-8","article-title":"Effect of DMARDs on the immunogenicity of vaccines","volume":"19","author":"van Sleen","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaip.2023.08.038_bib146","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002871","article-title":"Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease: an extension study (RESCUE 2)","volume":"9","author":"Tran","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.jaip.2023.08.038_bib147","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1093\/rheumatology\/keab223","article-title":"COVID-19 vaccination and antirheumatic therapy","volume":"60","author":"Arnold","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaip.2023.08.038_bib153","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jaad.2018.07.048","article-title":"Dupilumab does not affect correlates of vaccine-induced immunity: a randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis","volume":"80","author":"Blauvelt","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2023.08.038_bib154","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/all.15540","article-title":"The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients","volume":"78","author":"Ungar","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.08.038_bib155","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1164\/rccm.202111-2496LE","article-title":"Reduced COVID-19 vaccine response in patients treated with biologic therapies for asthma","volume":"205","author":"Runnstrom","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.08.038_bib160","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1007\/s10067-022-06329-2","article-title":"Janus kinase (JAK) inhibitors significantly reduce the humoral vaccination response against SARS-CoV-2 in patients with rheumatoid arthritis","volume":"41","author":"Sch\u00e4fer","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaip.2023.08.038_bib165","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/JAA.S172338","article-title":"ALIZE study investigators. Benralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from the phase IIIb ALIZE trial","volume":"11","author":"Zeitlin","year":"2018","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.jaip.2023.08.038_bib166","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1164\/rccm.202203-0599LE","article-title":"SARS-CoV-2 mRNA vaccine antibody response in patients with asthma receiving biologic therapy: a real-world analysis","volume":"206","author":"Liao","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.08.038_bib168","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1111\/jocd.14484","article-title":"The effect of COVID-19 on patients with chronic spontaneous urticaria treated with omalizumab and antihistamines: a cross-sectional, comparative study","volume":"20","author":"Bostan","year":"2021","journal-title":"J\u00a0Cosmet Dermatol"},{"key":"10.1016\/j.jaip.2023.08.038_bib169","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0152-2021","article-title":"Asthma and COVID-19: an update","volume":"30","author":"Adir","year":"2021","journal-title":"Eur Respir Rev"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823009625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823009625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:38:25Z","timestamp":1761975505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823009625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":165,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2213219823009625"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2023.08.038","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 and Its Impact on Common Diseases in the Allergy Clinics","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2023.08.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}